Product
Naltrexone-Bupropion
Aliases
Contrave, Naltrexone-Bupropion Combination
3 clinical trials
4 indications
Indication
ObesityIndication
MorbidIndication
Bariatric Surgery CandidateIndication
Medication PersistenceClinical trial
A Phase IV Study to Assess the Effect of Naltrexone Hydrochloride Extended Release (ER) and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on the Occurrence of Major Adverse Cardiovascular EventsStatus: Recruiting, Estimated PCD: 2029-01-01
Clinical trial
Association of Genetic Variations and Weight Loss Response to Naltrexone/BupropionStatus: Recruiting, Estimated PCD: 2027-06-30
Clinical trial
Use of Mysimba in Patients With Weight Regain After Bariatric SurgeryStatus: Recruiting, Estimated PCD: 2025-03-01